Skip to main content

Table 1 Clinical characteristics of HFrEF patients and control subjects

From: Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity

Characteristic Controls n = 8 HFrEF n = 8 p-value
Age (years) 55 ± 1.8 53 ± 4.5 0.939
Gender (% male) 62.5 % 62.5 % 1.000
Weight (Kg) 83.1 ± 6.4 74.6 ± 6.8 0.367
BMI (Kg/m2) 27.0 ± 1.3 23.3 ± 1.7 0.088
LVEF (%) N.A. 31.3 ± 6.0 N.A.
Total cholesterol (mmol/L) 5.02 ± 0.18 4.45 ± 0.51 0.469
HDL (mmol/L) 1.53 ± 0.15 1.25 ± 0.24 0.101
LDL (mmol/L) 3.05 ± 0.29 2.52 ± 0.42 0.363
Triglycerides (mmol/L) 1.00 ± 0.09 1.77 ± 0.17 0.003
Glucose (mmol/L) 4.75 ± 0.16 5.51 ± 0.39 0.151
Serum Creatinine (mmol/L) 76.91 ± 3.54 103.43 ± 17.68 0.279
hsCRP (mg/L) <2.9 22.0 ± 11.3 0.007
  1. N, Number of subjects; HFrEF, Heart failure with reduced ejection fraction; BMI, Body mass index; LVEF, Left Ventricular Ejection fraction; HDL, High density lipoprotein; LDL, Low density lipoprotein; hsCRP, high sensitivity C-reactive protein. Significant p-values are highlighted in bold. Data are expressed as mean ± SEM